Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms
A Gunes, ML Dahl - Pharmacogenomics, 2008 - Taylor & Francis
CYP1A2 is involved in the metabolism of several widely used drugs and endogenous
compounds, and in the activation of procarcinogens. Both genetic and environmental factors …
compounds, and in the activation of procarcinogens. Both genetic and environmental factors …
Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms
A Gunes, ML Dahl - Pharmacogenomics, 2008 - cir.nii.ac.jp
抄録< jats: p> CYP1A2 is involved in the metabolism of several widely used drugs and
endogenous compounds, and in the activation of procarcinogens. Both genetic and …
endogenous compounds, and in the activation of procarcinogens. Both genetic and …
Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms
A Gunes, ML Dahl - Pharmacogenomics (London), 2008 - diva-portal.org
CYP1A2 is involved in the metabolism of several widely used drugs and endogenous
compounds, and in the activation of procarcinogens. Both genetic and environmental factors …
compounds, and in the activation of procarcinogens. Both genetic and environmental factors …
Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms.
A Gunes, ML Dahl - Pharmacogenomics, 2008 - europepmc.org
CYP1A2 is involved in the metabolism of several widely used drugs and endogenous
compounds, and in the activation of procarcinogens. Both genetic and environmental factors …
compounds, and in the activation of procarcinogens. Both genetic and environmental factors …
Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms
A Gunes, ML Dahl - Pharmacogenomics, 2008 - go.gale.com
The CYP enzyme superfamily is involved in the biotransformation of exogenous and
endogenous compounds and accounts for most of phase I drug metabolism [1]. Among the …
endogenous compounds and accounts for most of phase I drug metabolism [1]. Among the …
Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms
A Gunes, ML Dahl - Pharmacogenomics (London), 2008 - swepub.kb.se
CYP1A2 is involved in the metabolism of several widely used drugs and endogenous
compounds, and in the activation of procarcinogens. Both genetic and environmental factors …
compounds, and in the activation of procarcinogens. Both genetic and environmental factors …
Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms
A Gunes, ML Dahl - Pharmacogenomics, 2008 - pubmed.ncbi.nlm.nih.gov
CYP1A2 is involved in the metabolism of several widely used drugs and endogenous
compounds, and in the activation of procarcinogens. Both genetic and environmental factors …
compounds, and in the activation of procarcinogens. Both genetic and environmental factors …
Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms
A Gunes - Pharmacogenomics, 2008 - search.proquest.com
CYP1A2 is involved in the metabolism of several widely used drugs and endogenous
compounds, and in the activation of procarcinogens. Both genetic and environmental factors …
compounds, and in the activation of procarcinogens. Both genetic and environmental factors …
[引用][C] Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms
A GUNES - Pharmacogenomics, 2008 - cir.nii.ac.jp
Variation in CYP1A2 activity and its clinical implications : influence of environmental factors
and genetic polymorphisms | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
and genetic polymorphisms | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …